Latest News

Medical device mass tort TV advertising saw a strong start in Q1 2026, with roughly 1,200 ads in January, but activity declined steadily through March, driving the quarter to the lowest overall ad volume and spend levels in over a decade.

AdvaMed’s Q4 2025 medical device litigation TV advertising report shows a strong start to the quarter followed by a typical year-end slowdown. Ad volume declined 6% from Q3, but total spending increased 6%, with November reaching a new monthly high of approximately $280K.

Medical device mass tort TV advertising ticked up in Q3 2025, with ad volume rising 19% and each month topping 1,000 ads. August led the quarter with more than 1,200 ads and about $234,000 in spending.